China Vascular Graft Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the China Vascular Graft Market was valued at USD 1.39 billion in 2025 and is projected to reach USD 2.31 billion by 2032, growing at a CAGR of approximately 7.5% during 2026–2032.
China Vascular Graft Market Highlights
| Report Metric | Details |
| Report Name | China Vascular Graft Market |
| Market Size 2025 | USD 1.39 billion |
| Market Size 2032 | USD 2.31 billion |
| Absolute Growth 2025–2032 | USD 0.92 billion |
| CAGR 2026–2032 | 7.5% |
| Peak Annual Growth | 10.0% in 2030 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Graft Source, 2025 | Synthetic Grafts (36% share) |
| Leading Configuration, 2025 | Tubular/Bifurcated (45% share) |
| Leading Fixation Type, 2025 | Stapled/Sutured (36% share) |
| Leading End User, 2025 | Hospitals (41% share) |
| Fastest-Growing Graft Source | Hybrid Grafts (9.7% CAGR) |
| Fastest-Growing Configuration | 3D Printed (9.3% CAGR) |
| Fastest-Growing Fixation Type | Self-Expanding (10.0% CAGR) |
| Fastest-Growing End User | Cardiovascular Clinics (10.2% CAGR) |
| Growing Sector | Cardiovascular Health |
| Key End Users | Hospitals, Cardiovascular Clinics, Surgical Centers |
China Vascular Graft Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
The table below sets out the estimated growth rate for each year and the main factor behind it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 7.2 | The market experienced steady growth due to increased vascular surgeries across hospitals. |
| 2023 | 6.1 | Growth slowed as hospitals faced supply chain disruptions affecting graft availability. |
| 2024 | 7.1 | Demand rose with advancements in surgical techniques improving patient outcomes. |
| 2025 | 8.0 | Growth accelerated as hospitals expanded vascular surgery capabilities and facilities. |
| 2026 | 8.5 | Investment in graft technologies is expected to boost market performance this year. |
| 2027 | 5.3 | Growth will slow as regulatory approvals for new products face delays. |
| 2028 | 6.6 | Demand is projected to increase as awareness campaigns gain traction. |
| 2029 | 7.2 | The market will grow as hospitals adopt more durable synthetic grafts. |
| 2030 | 10.0 | A peak in growth is anticipated with the introduction of advanced graft technologies. |
| 2031 | 7.3 | Growth will slow as competition intensifies among graft manufacturers. |
| 2032 | 7.8 | The market is expected to grow as personalized graft solutions become more common. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
China Vascular Graft Market Synopsis
The Vascular Graft market in China includes medical devices designed to replace or repair damaged blood vessels. These grafts are primarily constructed from synthetic materials or biological tissues and play a crucial role in treating vascular diseases. Demand is driven by over 2 million patients needing grafts each year and around 1,000 hospitals conducting vascular surgeries. Initiatives such as 'Healthy China 2030' promote cardiovascular health, further increasing the need for vascular grafts.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Increasing patient population requiring vascular surgeries | Driver | High | Synthetic Grafts |
| Investment in advanced graft technologies | Driver | High | Hybrid Grafts |
| Rising number of cardiovascular clinics | Opportunity | High | Cardiovascular Clinics |
| Growing demand for personalized grafts with 3D printing | Opportunity | Medium | Custom Grafts |
| Regulatory delays in product approvals | Restraint | High | Biological Grafts |
| Supply chain disruptions affecting graft availability | Restraint | Medium | Synthetic Grafts |
| Intense competition among graft manufacturers | Challenge | High | Hybrid Grafts |
| High costs of innovative graft technologies | Challenge | Medium | 3D Printed |
Evaluation of Drivers in China Vascular Graft Market (2026–2032)
The factors lifting demand, and the evidence behind each, are summarised below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Increased vascular surgeries performed in hospitals | Synthetic Grafts | With approximately 1,000 hospitals performing vascular surgeries, demand for synthetic grafts is rising. |
| Investment in graft technologies | Hybrid Grafts | Funding for research on hybrid grafts is boosting demand for these products. |
| Expansion of cardiovascular clinics | Cardiovascular Clinics | Over 500 cardiovascular clinics in urban areas are driving demand for grafts to treat patients. |
| Growing awareness of cardiovascular health | Biological Grafts | The 'Healthy China 2030' initiative is increasing awareness and demand for biological grafts. |
| Advancements in 3D printing technology | Custom Grafts | The demand for personalized fit grafts is expected to grow with advancements in 3D printing technology. |
The Vascular Graft market in China is expanding as investment in technologies, the rising number of vascular surgeries, and increasing awareness of cardiovascular health drive demand. Approximately 1,000 hospitals are performing vascular surgeries, creating a strong need for grafts. Awareness campaigns are expected to increase purchases of biological grafts, while advancements in 3D printing technology are set to drive the demand for personalized fit grafts. The expansion of cardiovascular clinics is further supporting growth in this market.
Evaluation of Restraints in China Vascular Graft Market
Below mentioned are some major restraints and their influence on market dynamics.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Regulatory delays in product approvals | Biological Grafts | The Chinese FDA's lengthy approval process for new biological grafts can hinder market entry. |
| Supply chain disruptions affecting graft availability | Synthetic Grafts | Supply chain issues have led to inconsistent availability of synthetic grafts in hospitals. |
| High costs of graft technologies | 3D Printed | The development costs for 3D printed grafts can limit their affordability for hospitals. |
| Intense competition among graft manufacturers | Hybrid Grafts | Increased competition may lead to price wars, affecting profit margins for manufacturers. |
| Limited awareness of advanced graft options | Custom Grafts | Some hospitals may not be aware of the benefits of custom grafts, limiting their adoption. |
China Vascular Graft Market Challenges
The China vascular graft market faces a critical supply issue, as inconsistent availability of high-quality raw materials disrupts production schedules for manufacturers. Hospitals, as primary buyers, experience delays in receiving grafts, which can postpone surgeries by an average of 7 days. A shortage of skilled vascular surgeons further complicates the situation, limiting the number of procedures performed annually and affecting over 2 million patients who require grafts. Compliance with ISO 7198:2016 standards raises manufacturing costs, forcing suppliers to increase prices, which ultimately strains hospitals' budgets for cardiovascular treatments.
Trends in the China Vascular Graft Market
Below mentioned are some of the trends shaping the China Vascular Graft Market growth.
- Shift Towards 3D Printed Grafts: In 2023, major cities in China began testing 3D printed grafts in clinical trials, with a focus on personalized solutions. This shift is anticipated to improve patient outcomes and increase demand for tailored grafts.
- Rise in Hybrid Grafts Adoption: Since 2022, the Jiangsu province has seen a surge in the use of hybrid grafts, with a projected CAGR of 9.7%. This trend indicates a growing preference for grafts that combine materials for better compatibility.
- Increased Focus on Biological Grafts: The Beijing Health Bureau implemented guidelines in 2022 promoting the use of biological grafts, leading to a rise in their adoption. This shift is attributed to their compatibility with human tissue.
- Expansion of Cardiovascular Clinics: The number of cardiovascular clinics in urban areas increased by over 10% in 2022, reflecting a growing focus on specialized vascular treatments. This expansion supports higher demand for vascular grafts.
Investment Opportunities in the China Vascular Graft Market
Some of the investment opportunities in the China Vascular Graft Market are mentioned below.
- Jiangsu Province Medical Facilities: Jiangsu province is home to advanced medical facilities specialising in vascular surgeries, with a budget of 1 billion yuan allocated for cardiovascular health in 2023. This creates opportunities for suppliers of grafts.
- Cardiovascular Clinics: With over 500 cardiovascular clinics operating, there is a notable opportunity to supply advanced graft technologies. Collaborating with these clinics can enhance market presence and drive sales.
- 3D Printed Grafts: The demand for 3D printed grafts is growing as hospitals seek personalised solutions. Investing in this technology can provide a competitive edge in the market.
- Approval Pathways for Grafts: The fast-track approval pathway established by the National Medical Products Administration offers a route for new graft technologies. Engaging with this pathway can expedite market entry.
Government Initiatives in the China Vascular Graft Market
The National Health Commission oversees the implementation of various health initiatives, including the 'Cardiovascular Disease Prevention and Control Program' launched in 2021. This program funds hospitals to improve their vascular treatment capabilities, with a focus on enhancing patient care. The State Administration for Market Regulation updated the 'Regulations on the Supervision and Administration of Medical Devices' in 2023 to streamline approval processes for medical devices, including vascular grafts. This change is projected to expedite the introduction of new graft technologies, benefiting both producers and buyers.
Hospitals utilize the 'Medical Device Innovation Action Plan' to access funding for advanced graft technologies. This initiative encourages hospitals to adopt new devices, improving patient care. The National Medical Products Administration is responsible for approving these technologies, ensuring they meet safety standards. This support facilitates faster access to new graft solutions for healthcare providers, enhancing treatment options for patients.
Future Insight of the China Vascular Graft Market
The China vascular graft market will undergo notable transformation by 2032, driven by advancements in 3D printing technology that will enable the production of personalised fit grafts. The 'Healthy China 2030' initiative will allocate 1 billion yuan for cardiovascular health programmes in 2023, enhancing access to grafts nationwide. Clinical trials for 3D printed grafts in major cities will introduce innovative surgical options. Support from the Ministry of Science and Technology for hybrid graft technologies will expand the product range available, benefiting both suppliers and hospitals.
Market Segmentation Analysis
The analysis below covers each segmentation, its leading category in 2025 and its fastest-growing category through 2032.
By Graft Source – Synthetic Grafts Dominated, Hybrid Grafts Expected to Grow Fastest
According to Bhawna Singh, Assistant Manager at 6Wresearch, the largest graft source category in 2025 was Synthetic Grafts, with a 36% share of total revenue. Synthetic grafts dominate the market share due to their widespread use in vascular repairs, supported by over 1,000 hospitals performing related surgeries across China. Their durability and lower rejection rates make them a preferred option for healthcare providers, ensuring consistent demand. Hybrid Grafts are set to record the highest CAGR in this split, 9.7% over 2026–2032. The growth of hybrid grafts is propelled by technological advancements, particularly through research initiatives backed by the Ministry of Science and Technology. As these innovations progress, hybrid grafts are expected to gain traction in specific clinical applications. Suppliers should focus on increasing the availability of hybrid grafts to meet the rising demand for specialised vascular solutions.
By Configuration – Tubular/Bifurcated Dominated, 3D Printed Expected to Grow Fastest
In 2025, Tubular/Bifurcated led the configuration split with a 45% share. Tubular and bifurcated configurations are the most common in vascular applications, meeting the needs of numerous hospitals conducting vascular surgeries. Their established presence in clinical practice reinforces their leading market share in the vascular graft sector. 3D Printed is projected to grow fastest, at a CAGR of 9.3% during 2026–2032. 3D printed grafts are emerging as a significant technology, with a growing emphasis on custom solutions tailored to individual patient needs. As healthcare facilities adopt this technology, the market share for 3D printed grafts is set for rapid growth. Buyers should consider 3D printed graft options to enhance treatment outcomes and improve patient satisfaction.
By Fixation Type – Stapled/Sutured Dominated, Self-Expanding Expected to Grow Fastest
With a 36% revenue share in 2025, Stapled/Sutured was the largest fixation type category. Stapled fixation is the traditional method for securing grafts, widely used across hospitals in China due to its proven reliability. This established practice plays a vital role in maintaining its leading market share in the vascular graft sector. The quickest growth will come from Self-Expanding, forecast to expand at a CAGR of 10.0% between 2026 and 2032. Self-expanding fixation types are gaining popularity in specific vascular conditions, offering ease of use and effective performance. As awareness of their benefits increases, their market share is likely to rise. Suppliers should promote self-expanding fixation options to align with the evolving preferences of healthcare providers.
By End User – Hospitals Dominated, Cardiovascular Clinics Expected to Grow Fastest
Hospitals took a 41% share of end user in 2025, more than any other category. Hospitals are the primary end users of vascular grafts, with a significant number of facilities conducting vascular surgeries annually. Their extensive infrastructure and high patient volume are crucial in sustaining their dominant market share. Over 2026–2032, Cardiovascular Clinics are expected to post the fastest growth, at a CAGR of 10.2%. Cardiovascular clinics are rapidly growing as specialised centres for vascular treatment, driven by an increasing patient population requiring targeted care. Their focus on cardiovascular health positions them for continued market growth. Suppliers should strengthen partnerships with cardiovascular clinics to capitalise on opportunities in this expanding segment.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- China Vascular Graft Market Outlook
- Market Size of China Vascular Graft Market, 2025
- Forecast of China Vascular Graft Market, 2032
- Historical Data and Forecast of China Vascular Graft Revenues & Volume for the Period 2022 - 2032F
- China Vascular Graft Market Trend Evolution
- China Vascular Graft Market Drivers and Challenges
- China Vascular Graft Price Trends
- China Vascular Graft Porter's Five Forces
- China Vascular Graft Industry Life Cycle
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Graft Source for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Synthetic Grafts for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Biological Grafts for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Hybrid Grafts for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Custom Grafts for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Configuration for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Tubular/Bifurcated for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Human/Animal Derived for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Composite Material for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By 3D Printed for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Fixation Type for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Stapled/Sutured for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Sutured for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Self-Expanding for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Personalized Fit for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Hospitals for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Cardiovascular Clinics for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Surgical Centers for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Graft Market Revenues & Volume By Specialized Labs for the Period 2022 - 2032F
- China Vascular Graft Import Export Trade Statistics
- Market Opportunity Assessment By Graft Source
- Market Opportunity Assessment By Configuration
- Market Opportunity Assessment By Fixation Type
- Market Opportunity Assessment By End User
- China Vascular Graft Top Companies Market Share
- China Vascular Graft Competitive Benchmarking By Technical and Operational Parameters
- China Vascular Graft Company Profiles
- China Vascular Graft Key Strategic Recommendations
Market Covered
This report examines the market across the segments below.
By Graft Source
- Synthetic Grafts
- Biological Grafts
- Hybrid Grafts
- Custom Grafts
By Configuration
- Tubular/Bifurcated
- Human/Animal Derived
- Composite Material
- 3D Printed
By Fixation Type
- Stapled/Sutured
- Sutured
- Self-Expanding
- Personalized Fit
By End User
- Hospitals
- Cardiovascular Clinics
- Surgical Centers
- Specialized Labs
